Zydus Lifesciences Limited has informed the Exchange regarding a press release dated August 29, 2025, titled "Zydus Therapeutics Reports Positive Topline Results from EPICS-III Phase 2(b)/3 Trial of Saroglitazar Magnesium in Patients with Primary Biliary Cholangitis".